2018
Heather Wachtel, MD
University of Pennsylvania
Circulating miRNA signatures in primary hyperparathyroidism
David Schneider, MD
University of Wisconsin
Using patient language for measuring quality of life in thyroid cancer
2017
Xavier Keutgen, MD
Rush University Medical Center
Transcriptional analysis of syndromic and sporadic pancreatic neuroendocrine tumors yields novel genotype specific targets
Raymon Grogan, MD
University of Chicago
Microbiome alterations and thyroid cancer risk
2016
Basic Science
Dhaval Patel, MD
National Institutes of Health
Comprehensive Metabolomic Analysis of Adrenocortical Carcinoma: Toward Improved Diagnosis, Prognosis and Therapeutic Targets
Clinical Research
Susan Pitt, MD, MPHS
University of Wisconsin
Decision-Making about Papillary Thyroid Microcarcinoma Treatment
2015
Basic Research
Brian Untch, MD
Memorial Sloan-Kettering Cancer Center
RTKs in Resistane to RAS Inhibition in Thyroid Cancer
Clinical Research
Insoo Suh, MD
Univeristy of California San Francisco
FDG-PET Imaging for Parathyroid Tumors
2014
Michael Stang, MD
University of Pittsburgh
Lysosome Centered Signaling and Regulation of Autophagy in a Model of Papillary Thyroid Carcinoma
2013
Jason D. Prescott, MD
Johns Hopkins School of Medicine
Development of a High Throughput in vivo Screening System for Small Molecule Activators of Thyroid Differentiation: In Search of Novel Agents for Treatment of Undifferentiated Thyroid Cancer
2012
Daniel Ruan, MD
Brigham and Women’s Hospital
Overcoming Medullary Thyroid Cancer Resistance to Vandetanib: Characterization of the Mechanisms
2011
Naris Nilubol, MD
National Cancer Institute
Identification and Validation of Novel Anticancer Compounds for the Treatment of Adrenocortical Cancer
2010
Rebecca S. Sippel, MD
University of Wisconsin – Madison
Characterization of Age-Related Changes in the Notch1 Pathway in Well-Differentiated Thyroid Cancers
|